Literature DB >> 25979646

Defining the High-Risk Population for Mortality After Resection of Early Stage NSCLC.

Zain A Husain1, Anthony W Kim2, James B Yu3, Roy H Decker3, Christopher D Corso3.   

Abstract

UNLABELLED: The National Cancer Data Base was examined for predictors of 30-day mortality (30-DM) in early stage none small-cell lung cancer patients undergoing resection. The rate of 30-DM was 2.2%. Age, community treatment center, male sex, and Charlson-Deyo comorbidity score were predictive of higher mortality. Extent of resection was predictive of higher 30-DM in patients aged ‡ 75 years.
BACKGROUND: Studies examining morbidity after lobectomy for early stage non-small-cell lung cancer (NSCLC) demonstrate a > 50% incidence of complications in patients aged ≥ 65 years. Factors that affect 30-day mortality (30-DM), however, are less well defined.
MATERIALS AND METHODS: The National Cancer Data Base was used to identify patients age ≥ 19 years with stage I NSCLC between 2003 and 2011. Data from patients undergoing lobectomy or sublobar resection was abstracted. Univariable and multivariable logistic regression analyses were performed for predictors of 30-DM.
RESULTS: A total of 71,175 patients met inclusion criteria. Of these, 81% underwent lobectomy and 19% underwent sublobar resection. The median age was 68 years. Charlson-Deyo (CD) comorbidity score was 0 in 49% of patients and 1 or higher in 51%. The rate of 30-DM was 2.2%. On multivariable analysis, younger age, CD score of 0, female sex, tumor size ≤ 3 cm, and treatment at an academic center was associated with lower 30-DM (P < .001). A model of 30-DM incorporating age, comorbidity, and extent of surgery was created. In patients aged < 75 years without comorbidities, 30-DM was 1.3%. However, in elderly patients (≥ 75 years old) with CD score of 2, this rate quadrupled to 5.8% (P < .01). Lobectomy patients in this group had higher 30-DM compared to sublobar resection patients (6.6% vs. 3.9% respectively, P < .01).
CONCLUSION: The 30-DM rate following sublobar or lobar resection in this national sample was low. Extent of resection appears to influence 30-DM in the elderly. Elderly patients with a CD score of 2 undergoing lobectomy represent a high-risk group for 30-DM.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  30-day mortality; Lobectomy; NCDB; NSCLC; Sublobar resection

Mesh:

Year:  2015        PMID: 25979646     DOI: 10.1016/j.cllc.2015.04.007

Source DB:  PubMed          Journal:  Clin Lung Cancer        ISSN: 1525-7304            Impact factor:   4.785


  11 in total

1.  Optimizing selection of candidates for lung cancer screening: role of comorbidity, frailty and life expectancy.

Authors:  Shailesh Advani; Dejana Braithwaite
Journal:  Transl Lung Cancer Res       Date:  2019-12

Review 2.  A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 2: systematic review of evidence regarding resection extent in generally healthy patients.

Authors:  Frank C Detterbeck; Vincent J Mase; Andrew X Li; Ulas Kumbasar; Brett C Bade; Henry S Park; Roy H Decker; David C Madoff; Gavitt A Woodard; Whitney S Brandt; Justin D Blasberg
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

3.  Invasive Procedures and Associated Complications After Initial Lung Cancer Screening in a National Cohort of Veterans.

Authors:  Eduardo R Núñez; Tanner J Caverly; Sanqian Zhang; Mark E Glickman; Shirley X Qian; Jacqueline H Boudreau; Donald R Miller; Renda Soylemez Wiener
Journal:  Chest       Date:  2022-02-26       Impact factor: 10.262

4.  Impact of comorbidity burden on morbidity following thoracoscopic lobectomy: a propensity-matched analysis.

Authors:  Ruoyu Zhang; Thomas Kyriss; Jürgen Dippon; Sebastian Ciupa; Enole Boedeker; Godehard Friedel
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

5.  A systematic review of risk prediction models for perioperative mortality after thoracic surgery.

Authors:  Marcus Taylor; Syed F Hashmi; Glen P Martin; Michael Shackcloth; Rajesh Shah; Richard Booton; Stuart W Grant
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-04-08

6.  Prognostic Value of Preoperative Peak Expiratory Flow to Predict Postoperative Pulmonary Complications in Surgical Lung Cancer Patients.

Authors:  Shuai Chang; Kun Zhou; Yan Wang; Yutian Lai; Guowei Che
Journal:  Front Oncol       Date:  2021-11-22       Impact factor: 6.244

7.  Knockdown of LncRNA LINC00958 Inhibits the Proliferation and Migration of NSCLC Cells by MiR-204-3p/KIF2A Axis.

Authors:  Qing Wang; Kai Li; Xiaoliang Li
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

8.  Real-world treatment patterns for patients 80 years and older with early lung cancer: a nationwide claims study.

Authors:  Kyungjong Lee; Hye Ok Kim; Hee Kyoung Choi; Gi Hyeon Seo
Journal:  BMC Pulm Med       Date:  2018-08-03       Impact factor: 3.317

9.  Safety and clinical outcomes of computed tomography-guided percutaneous microwave ablation in patients aged 80 years and older with early-stage non-small cell lung cancer: A multicenter retrospective study.

Authors:  Xiaoying Han; Xia Yang; Guanghui Huang; Chunhai Li; Licheng Zhang; Yuanxun Qiao; Chuntang Wang; Yuting Dong; Xiangming Chen; Qingliang Feng; Chuandai Wang; Zhenhua Rong; Kun Ding; Zhigang Wei; Yang Ni; Jiao Wang; Wenhong Li; Min Meng; Xin Ye
Journal:  Thorac Cancer       Date:  2019-11-03       Impact factor: 3.500

10.  Virtual randomized study comparing lobectomy and particle beam therapy for clinical stage IA non-small cell lung cancer in operable patients.

Authors:  Young-Seok Seo; Woo-Yoon Park; Si-Wook Kim; Dohun Kim; Byung Jun Min; Won-Dong Kim
Journal:  J Radiat Res       Date:  2021-09-13       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.